Identification of a novel human receptor tyrosine kinase gene
CA 2083401 C · Owner: Wyeth Holdings Corporation · Inventors: Carrion, Miguel E.; Terman, Bruce I.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A DNA sequence encoding a novel human growth factor receptor referred to as a type III receptor tyrosine kinase is described. The amino acid sequence of the receptor is also described. The receptor has a sequence which is similar to that of the kinase domains of known type III receptor tyrosine kinases but which is unique , in its kinase insert domain sequence. The receptor binds specifically to the vascular endothelial cell growth factor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 20, 1992 and granted March 25, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 20, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 20, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.